HDAC6 score found to predict the response of some cancers to ricolinostat

Digital transformation conceptual for next generation technology era

A team of researchers affiliated with a host of medical institutions across the U.S. has found that the HDAC6 score can be used to predict the response of some types of cancer to administration of the histone ricolinostat.

The power of lines and strokes: How our brain recognizes line drawings

Previous article

To prevent HIV, ease intimate partner violence

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations